July 4, 2024 From Canadian HRReporter
A new study in British Columbia funded by GenomeBC and the B.C. Ministry of Health is exploring how genetic testing can enhance treatment for individuals with clinical depression. This research aims to address accessibility concerns and leverage genetic testing to improve patient outcomes, reduce costs, and provide more accurate prescribing.
The Promise and Perils of Genetic Testing
Employers are increasingly offering genetic testing as part of their benefits packages through third-party labs. This initiative promises faster, more effective treatments and cost savings. However, it also raises questions about equity in the workplace.
Dr. Jehannine Austin, co-leader of the project and professor at the University of British Columbia, highlights a significant concern: “the problem with offering this through employment plans is that it introduces opportunities for inequities straight off the bat. That’s why we’ve been looking at this from the perspective of ‘What if this was covered, but for everyone through the provincial health care plan, rather than for people who happen to be employed in jobs where this is one of the benefits?’”
Potential Cost Savings and Improved Treatments
Genetic testing can lead to substantial savings in healthcare costs. A 2022 study by Austin and their team revealed that providing genetic testing for individuals with major depression could save the B.C. healthcare system approximately $1 billion over 20 years. The testing would help patients find effective medications faster, reducing the number of people labeled as having treatment-resistant depression.
Pascale Mapleston, founder and CEO of The Benefit Code, recognizes the immediate benefits for employers: “I’m happy to hear that we’re moving away from ‘medication first.’ Now we’re talking about mindfulness, diet, lifestyle, and potentially a medication being part of that holistic approach to managing your mental health.”
Privacy and Ethical Considerations
While the benefits are clear, ethical and privacy concerns remain. Genetic testing is currently accessible only to those who can afford private testing or whose employers offer it as a benefit. To bridge this gap, the research aims to make genetic testing for depression publicly available.
Legislation like the Genetic Non-Discrimination Act of 2020 protects data from genetic tests. However, experts note potential loopholes. Employers must implement stringent safeguards to protect employee privacy. Austin emphasizes the need for robust protections: “There have to be really good safeguards in place between the genetic test results and the employer knowing the results of those tests, or even that the test was being ordered.”
=================================================================
Considering an IME or document review to resolve an insurance claim, legal file, or workplace health and safety issue?
Our specialists provide evidence-based opinions, so get in touch with Western Medical today to learn more about our services.